Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTMT1 | Q9BV86 | 17/20 | 0.54 |
| ▸ | UGCG | Q16739 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19407264 | 0.92 | NTMT1 (0.62) | NTMT1 | |
| SCHEMBL19844441 | 0.90 | NTMT1 (0.61) | NTMT1UGCG | |
| SCHEMBL12696495 | 0.90 | NTMT1 (0.61) | NTMT1UGCG | |
| SCHEMBL19844440 | 0.90 | NTMT1 (0.61) | NTMT1UGCG | |
| SCHEMBL29387425 | 0.90 | NTMT1 (0.61) | NTMT1UGCG | |
| SCHEMBL19837252 | 0.85 | NTMT1 (0.51) | NTMT1UGCG | |
| SCHEMBL29356676 | 0.85 | NTMT1 (0.51) | NTMT1UGCG | |
| SCHEMBL16006996 | 0.84 | NTMT1 (0.66) | NTMT1UGCG | |
| SCHEMBL16006997 | 0.84 | NTMT1 (0.66) | NTMT1UGCG | |
| SCHEMBL29400492 | 0.83 | NTMT1 (0.50) | NTMT1UGCGALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210379031-A1 | BIOMARKER OF POLYCYSTIC KIDNEY DISEASE AND USES THEREOF | GENZYME CORPORATION (US) | 2021-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210379031-A1 | BIOMARKER OF POLYCYSTIC KIDNEY DISEASE AND USES THEREOF | PKD2, PKD1, KLKB1 | NTMT1 1332/4885UGCG 3455/4885ALDH1A1 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.